Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders

NCT: NCT05386134 · RECRUITING

NCT IDNCT05386134
StatusRECRUITING
Start Date2022-06-13
Completion2033-06-13

Brief Summary

This is a Prospective Observational study. The aim of the study is to understand the underlying photoreceptor, retinal pigment epithelium or retinal vascular aberrations in inherited and acquired retinal disorders. The study would use adaptive optics (AO) technology to assist in-vivo visualization of these retinal structures and ascertain changes from normal. Further, by using the AO imaging in patients before and after treatments, this study aims to better understand the effect of various interventions and develop AO as an outcome measure in various retinal disorders.

Frequently Asked Questions

What is Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders?

Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders is a clinical trial registered under NCT05386134. Current status: RECRUITING.

What is the status of NCT05386134?

The current status of NCT05386134 (Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders) is: RECRUITING.

When did Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders start?

Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders started on 2022-06-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.